Literature DB >> 18036987

The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion.

Ulrich J H Sachs1.   

Abstract

Transfusion-related acute lung injury (TRALI) is a serious, life-threatening complication of blood transfusion. Available evidence strongly suggests that leukocyte antibodies present in donor plasma are the predominant mechanism in TRALI. These antibodies lead to recipient neutrophil activation, with activated neutrophils inducing endothelial and alveolar damage in the lungs. These mechanisms are discussed in detail as are the alternative mechanisms that have been proposed. Preventive strategies that may help to reduce TRALI are presented.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18036987     DOI： 10.1016/j.transci.2007.02.005

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN： 1473-0502            Impact factor:   1.764


  9 in total

Review 1.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

2.  Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.

Authors:  David M Harris; Inbal Hazan-Haley; Kevin Coombes; Carlos Bueso-Ramos; Jie Liu; Zhiming Liu; Ping Li; Murali Ravoori; Lynne Abruzzo; Lin Han; Sheela Singh; Michael Sun; Vikas Kundra; Razelle Kurzrock; Zeev Estrov
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

Review 3.  Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.

Authors:  Alexander B Benson; Marc Moss; Christopher C Silliman
Journal:  Br J Haematol       Date:  2009-08-05       Impact factor: 6.998

4.  Mir-218 contributes to the transformation of 5-Aza/GF induced umbilical cord mesenchymal stem cells into hematopoietic cells through the MITF pathway.

Authors:  Kaimeng Hu; Chen Xu; Haitao Ni; Zhenyu Xu; Yue Wang; Sha Xu; Kaihong Ji; Jun Xiong; Houqi Liu
Journal:  Mol Biol Rep       Date:  2014-04-03       Impact factor: 2.316

Review 5.  Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update.

Authors:  Susan A Kuldanek; Marguerite Kelher; Christopher C Silliman
Journal:  Expert Rev Hematol       Date:  2019-07-16       Impact factor: 2.929

6.  Two cases of transfusion-related acute lung injury triggered by HLA and anti-HLA antibody reaction.

Authors:  Ji Hyun Lee; Eun-Suk Kang; Dae-Won Kim
Journal:  J Korean Med Sci       Date:  2010-08-12       Impact factor: 2.153

7.  Effects of blood products on inflammatory response in endothelial cells in vitro.

Authors:  Martin Urner; Inge K Herrmann; Felix Buddeberg; Caroline Schuppli; Birgit Roth Z'graggen; Melanie Hasler; Urs Schanz; Manuela Mehr; Donat R Spahn; Beatrice Beck Schimmer
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Survival analysis of intraoperative blood salvage for patients with malignancy disease: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Wei-Wei Wu; Wei-Yi Zhang; Wei-Han Zhang; Lei Yang; Xiao-Qian Deng; Meng-Chan Ou; Yao-Xin Yang; Hai-Bei Liu; Tao Zhu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 9.  Endothelial pathomechanisms in acute lung injury.

Authors:  Nikolaos A Maniatis; Anastasia Kotanidou; John D Catravas; Stylianos E Orfanos
Journal:  Vascul Pharmacol       Date:  2008-07-29       Impact factor: 5.773
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.